helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.
Company profile
Ticker
HSDT
Exchange
Website
CEO
Philippe Deschamps
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
HELIUS MEDICAL TECHNOLOGIES, INC
SEC CIK
Corporate docs
Subsidiaries
Helius Medical, Inc. • Helius Medical Technologies (Canada), Inc. • Helius NeuroRehab, Inc. • Helius Canada Acquisition Ltd. • Heuro Canada, Inc. ...
HSDT stock data
Latest filings (excl ownership)
8-K
Material Modifications to Rights of Security Holders
15 Mar 24
8-K
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
4 Mar 24
8-K
Other Events
9 Feb 24
8-K
Regulation FD Disclosure
4 Dec 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results
9 Nov 23
8-K
Results of Operations and Financial Condition
2 Nov 23
8-K
Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece
28 Sep 23
8-K
Other Events
5 Sep 23
8-K
Helius Medical Technologies Announces Reverse Stock Split
16 Aug 23
Transcripts
HSDT
Earnings call transcript
2023 Q2
10 Aug 23
HSDT
Earnings call transcript
2023 Q1
11 May 23
HSDT
Earnings call transcript
2022 Q4
9 Mar 23
HSDT
Earnings call transcript
2022 Q3
14 Nov 22
HSDT
Earnings call transcript
2022 Q2
15 Aug 22
HSDT
Earnings call transcript
2022 Q1
12 May 22
HSDT
Earnings call transcript
2021 Q4
15 Mar 22
HSDT
Earnings call transcript
2021 Q3
11 Nov 21
HSDT
Earnings call transcript
2021 Q2
13 Aug 21
HSDT
Earnings call transcript
2021 Q1
18 May 21
Latest ownership filings
4/A
DANE ANDREEFF
15 Feb 24
SC 13G/A
Avid Fund Services, LLC
13 Feb 24
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
SC 13G/A
Hudson Bay Capital Management LP
5 Feb 24
4
DANE ANDREEFF
15 Dec 23
4
DANE ANDREEFF
4 Dec 23
SC 13G
Avid Fund Services, LLC
31 Oct 23
SC 13D/A
ANDREEFF DANE
11 Sep 23
4
DANE ANDREEFF
30 Aug 23
4
EDWARD M STRAW
26 May 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.60 mm | 6.60 mm | 6.60 mm | 6.60 mm | 6.60 mm | 6.60 mm |
Cash burn (monthly) | 667.67 k | 841.00 k | 1.22 mm | 1.30 mm | 817.33 k | 877.08 k |
Cash used (since last report) | 3.98 mm | 5.01 mm | 7.28 mm | 7.74 mm | 4.87 mm | 5.23 mm |
Cash remaining | 2.62 mm | 1.58 mm | -679.68 k | -1.14 mm | 1.73 mm | 1.37 mm |
Runway (months of cash) | 3.9 | 1.9 | -0.6 | -0.9 | 2.1 | 1.6 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 1 |
Closed positions | 12 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 2.84 mm |
Total shares | 2.26 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Intracoastal Capital | 1.50 mm | $0.00 |
Columbus Capital Management | 324.68 k | $0.00 |
Hirschman Orin | 255.40 k | $1.33 mm |
Andreeff Dane | 184.32 k | $1.50 mm |
ST Germain D J | 122.00 | $23.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Dec 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 8.095 | 1,603 | 12.98 k | 12,879 |
14 Dec 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 8.095 | 570 | 4.61 k | 3,402 |
14 Dec 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 8.095 | 2,827 | 22.88 k | 16,512 |
1 Dec 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 6.448 | 643 | 4.15 k | 11,276 |
1 Dec 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 6.448 | 229 | 1.48 k | 2,832 |
1 Dec 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 6.448 | 1,134 | 7.31 k | 13,685 |
30 Nov 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 6.3704 | 641 | 4.08 k | 10,633 |
30 Nov 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 6.3704 | 228 | 1.45 k | 2,603 |
30 Nov 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 6.3704 | 1,131 | 7.20 k | 12,551 |
30 Aug 23 | Andreeff Dane | Common Stock | Buy | Acquire P | Yes | No | 7.6423 | 141 | 1.08 k | 599 |
News
Earnings Scheduled For March 28, 2024
28 Mar 24
Helius Medical Tech's Earnings Outlook
27 Mar 24
Helius Medical Technologies, Inc. Initiates Open-Label Study For Registrational Program In Stroke
12 Mar 24
Roth MKM Maintains Buy on Helius Medical Tech, Adjusts Price Target To $24
5 Mar 24
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
4 Mar 24
Press releases
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
15 Mar 24
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
12 Mar 24
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
7 Mar 24
Thinking about buying stock in SoundHound AI, Macy's, Ainos, Helius Medical Technologies, or Renalytix?
4 Mar 24
Thinking about buying stock in Helius Medical Technologies, Peraso, GDS Holdings, Everbridge, or Petros Pharmaceuticals?
6 Feb 24